Evaluation of the Diagnosis Performances of DEC LTS-2 Skin Patch for Onchocerciasis in Central Africa
- Conditions
- OnchocerciasisDiagnoses DiseaseLoiasisNeglected Diseases
- Interventions
- Diagnostic Test: LTS-2 DEC patchDiagnostic Test: Skin snips
- Registration Number
- NCT04035174
- Lead Sponsor
- Center for Research on Filariasis and Other Tropical Diseases, Cameroon
- Brief Summary
This study aims at evaluating the diagnosis performances of the LTS-2 DEC patch for onchocerciasis compared to the gold standard which are the skin snips. This study will be conducted in Cameroon in two different areas : Ngog-Mapubi and Bafia Health Districts (one area only endemic for onchocerciasis, and one area endemic for both loiasis and onchocerciasis).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- 1400
- All voluntary adults
- General acute infection (temperature ≥ 38,5°C)
- Impaired general condition
- Ivermectin taken in the 6 last months
- Known allergies to one of the component of the patch
- Dermatological acute infection (bacterial, atopic, prurigo, or zona)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Skin snip Skin snips A skin snip will be performed using a 2 mm Holth corneoscleral's punch. Once done, the microfilariae of Onchocerca volvulus will be counted with a microscope. LTS-2 DEC patch LTS-2 DEC patch This is a transdermal device with diethylcarbamazine (DEC) applied directly on the skin. The reading will be done 24 hours after. LTS-2 DEC patch Skin snips This is a transdermal device with diethylcarbamazine (DEC) applied directly on the skin. The reading will be done 24 hours after. Skin snip LTS-2 DEC patch A skin snip will be performed using a 2 mm Holth corneoscleral's punch. Once done, the microfilariae of Onchocerca volvulus will be counted with a microscope.
- Primary Outcome Measures
Name Time Method Feasibility of the patch 24 hours Proportion of individuals for whom the patches are spontaneously removed from the skin during the 24 hours.
Tolerability of the patch 24 hours Proportion of individuals having developed a generalized Mazzotti's reaction
- Secondary Outcome Measures
Name Time Method Diagnosis performances 24 hours Assessment of the sensibility, specificity, and predictive values of the LTS-2 DEC patch compared to the results from the skin snips.
Loiasis and cross-reactivity assessment 24 hours Loiasis impact of the diagnosis performances of the LTS-2 DEC patch. Loiasis will be assessed with thick blood smears and a microscopic examination ; and with PCR in the skin snips
Semi-quantitative scoring of the LTS-2 DEC patch results 24 hours Relationship between the number of microfilariae of O. volvulus and the skin reaction under the patch (0 no reaction, 1: \< 50% of the skin under the patch, 2: \>50% of the skin under the patch, and 3: reaction under all the skin surface of the patch)
Trial Locations
- Locations (1)
Centre de Recherche sur les filarioses et autres maladies tropicales (CRFilMT)
🇨🇲Yaoundé, Cameroon